ArticleInternational archives of allergy and immunology2011

Basophil CD203c levels are increased at baseline and can be used to monitor omalizumab treatment in subjects with nut allergy.

Yael Gernez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.